{"id":1470548,"title":"DSEN Abstract: No evidence identified interventions that decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin 5-hydroxytryptamine 3 receptor (5-HT3) antagonists - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-04-07","captureTimestamp":"2026-04-07T17:44:13.304000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/52121.html?wbdisable=true","snippet":"DSEN Abstract No evidence identified interventions that decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin 5-hydroxytryptamine 3 receptor (5-HT3) antagonists This research was funded by the Drug Safety and Effectiveness Network (DSEN)…","rawSnapshotUrl":"/api/snapshots/raw/1470548","browseUrl":"https://replay.healtharchive.ca/job-8/20260407174413/https://cihr-irsc.gc.ca/e/52121.html?wbdisable=true#ha_snapshot=1470548","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}